Bolt Biotherapeutics, Inc. (BOLT) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Bolt Biotherapeutics, Inc. (BOLT) Bundle
Explore the financial future of Bolt Biotherapeutics, Inc. (BOLT) with our user-friendly DCF Calculator! Enter your assumptions regarding growth, profit margins, and expenses to calculate the intrinsic value of Bolt Biotherapeutics, Inc. (BOLT) and inform your investment decisions.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .2 | .2 | 1.3 | 5.7 | 7.9 | 12.7 | 20.5 | 33.0 | 53.2 | 85.8 |
| Revenue Growth, % | 0 | 7.44 | 445.45 | 354.68 | 37.48 | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 |
| EBITDA | -30.6 | -48.6 | -91.6 | -88.7 | -74.3 | -12.7 | -20.5 | -33.0 | -53.2 | -85.8 |
| EBITDA, % | -14248.37 | -21026.41 | -7269.44 | -1547.48 | -943.91 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.3 | 2.5 | 3.7 | 4.9 | 1.9 | 10.4 | 16.7 | 27.0 | 43.5 | 70.2 |
| Depreciation, % | 618.14 | 1083.98 | 291.43 | 85.37 | 23.54 | 81.78 | 81.78 | 81.78 | 81.78 | 81.78 |
| EBIT | -32.0 | -51.1 | -95.3 | -93.5 | -76.2 | -12.7 | -20.5 | -33.0 | -53.2 | -85.8 |
| EBIT, % | -14866.51 | -22110.39 | -7560.87 | -1632.85 | -967.45 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 34.8 | 22.8 | 186.2 | 168.9 | 102.2 | 12.7 | 20.5 | 33.0 | 53.2 | 85.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventories | -.3 | .0 | -.2 | -.8 | .0 | -3.4 | -5.5 | -8.9 | -14.4 | -23.2 |
| Inventories, % | -139.53 | -5.19 | -15.87 | -13.96 | 0 | -27.01 | -27.01 | -27.01 | -27.01 | -27.01 |
| Accounts Payable | 2.1 | 1.6 | 3.6 | 3.6 | 3.0 | 10.2 | 16.4 | 26.5 | 42.6 | 68.8 |
| Accounts Payable, % | 974.42 | 691.77 | 283.65 | 62.73 | 37.93 | 80.13 | 80.13 | 80.13 | 80.13 | 80.13 |
| Capital Expenditure | -.5 | -3.3 | -2.3 | -2.0 | -.2 | -8.6 | -13.8 | -22.2 | -35.8 | -57.8 |
| Capital Expenditure, % | -236.28 | -1412.12 | -185.56 | -34.09 | -2.62 | -67.34 | -67.34 | -67.34 | -67.34 | -67.34 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -31.5 | -60.8 | -100.9 | -91.2 | -76.2 | -12.6 | -20.3 | -32.7 | -52.8 | -85.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -28.2 | -62.3 | -97.4 | -87.6 | -76.0 | -.1 | -9.0 | -14.5 | -23.4 | -37.8 |
| WACC, % | 6.54 | 6.58 | 6.58 | 6.52 | 6.58 | 6.56 | 6.56 | 6.56 | 6.56 | 6.56 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -65.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -39 | |||||||||
| Terminal Value | -846 | |||||||||
| Present Terminal Value | -616 | |||||||||
| Enterprise Value | -681 | |||||||||
| Net Debt | 9 | |||||||||
| Equity Value | -691 | |||||||||
| Diluted Shares Outstanding, MM | 38 | |||||||||
| Equity Value Per Share | -18.27 |
What You Will Get
- Real Bolt Biotherapeutics Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Bolt Biotherapeutics, Inc. (BOLT).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates tailored to BOLT.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Bolt Biotherapeutics’ fair value.
- Versatile Excel Template: Designed for quick edits, scenario testing, and detailed projections specific to BOLT.
- Time-Saving and Accurate: Skip building models from scratch while ensuring precision and flexibility for Bolt Biotherapeutics, Inc. (BOLT).
Key Features
- 🔍 Real-Life BOLT Financials: Pre-filled historical and projected data for Bolt Biotherapeutics, Inc. (BOLT).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Bolt’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Bolt’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Access the Model: Download and open the Excel file featuring Bolt Biotherapeutics, Inc.’s (BOLT) preloaded financial data.
- 2. Adjust Key Variables: Modify essential inputs such as projected growth rates, WACC, and capital expenditures.
- 3. Analyze Results in Real-Time: The DCF model automatically calculates intrinsic value and NPV based on your inputs.
- 4. Explore Different Scenarios: Evaluate various forecasts to assess different valuation possibilities.
- 5. Make Informed Decisions: Present detailed valuation analyses to back your strategic choices.
Why Choose This Calculator for Bolt Biotherapeutics, Inc. (BOLT)?
- Comprehensive Tool: Combines DCF, WACC, and financial ratio analyses tailored for biotechnology firms.
- Customizable Inputs: Modify yellow-highlighted cells to explore different investment scenarios.
- Detailed Insights: Automatically computes Bolt Biotherapeutics' intrinsic value and Net Present Value.
- Preloaded Data: Access to historical and projected data ensures reliable analysis.
- Professional Quality: Perfect for financial analysts, biotech investors, and corporate consultants.
Who Should Use This Product?
- Biotech Students: Understand drug development processes and apply them using real-world data.
- Researchers: Integrate advanced therapeutic models into academic studies or clinical research.
- Investors: Evaluate your own strategies and assess valuation metrics for Bolt Biotherapeutics, Inc. (BOLT).
- Industry Analysts: Enhance your analysis with a customizable model tailored for biotech evaluations.
- Pharmaceutical Entrepreneurs: Discover how large biotech firms like Bolt Biotherapeutics, Inc. (BOLT) are assessed in the market.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Bolt Biotherapeutics, Inc. (BOLT).
- Real-World Data: Bolt Biotherapeutics’ historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for decision-making.